ImmunoPrecise Antibodies Ltd. (IPA)
NASDAQ: IPA · Real-Time Price · USD
0.430
+0.013 (2.99%)
Nov 4, 2024, 4:00 PM EST - Market closed
ImmunoPrecise Antibodies Employees
As of April 30, 2024, ImmunoPrecise Antibodies had 101 total employees, including 72 full-time and 29 part-time employees. The number of employees decreased by 1 or -0.98% compared to the previous year.
Employees
101
Change (1Y)
-1
Growth (1Y)
-0.98%
Revenue / Employee
$172,692
Profits / Employee
-$198,976
Market Cap
12.40M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Apr 30, 2024 | 101 | -1 | -0.98% |
| Apr 30, 2023 | 102 | 17 | 20.00% |
| Apr 30, 2022 | 85 | 12 | 16.44% |
| Apr 30, 2021 | 73 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Star Equity Holdings | 171 |
| Evogene | 142 |
| Cosmos Health | 123 |
| Vivos Therapeutics | 123 |
| STRATA Skin Sciences | 99 |
| BiomX | 71 |
| Biora Therapeutics | 58 |
| Apollomics | 45 |
IPA News
- 15 hours ago - ImmunoPrecise to Host TECHDAY: Cutting-Edge AI and Biologics Innovation - Business Wire
- 7 days ago - ImmunoPrecise Advances Anti-Aging Research with Mayo Clinic Study, Poised to Tap into $81 Billion Market with AI Technology - Business Wire
- 14 days ago - ImmunoPrecise Antibodies to Participate at the AI Driven Drug Discovery Summit USA 2024 - Business Wire
- 19 days ago - Institutional Property Advisors Brokers $92.5 Million Multifamily Sale in L.A.'s NoHo Arts District - Business Wire
- 25 days ago - ImmunoPrecise Antibodies Celebrates Nobel Prize in Chemistry, Advances in AI-Powered Protein Design - Business Wire
- 4 weeks ago - ImmunoPrecise Subsidiary Signs Material Transfer Agreement with Biotheus - Business Wire
- 5 weeks ago - ImmunoPrecise Antibodies Advances Therapeutic Innovation with Groundbreaking Rabbit Antibody Developments - Business Wire
- 7 weeks ago - ImmunoPrecise Antibodies Ltd. (IPA) Q1 2025 Earnings Call Transcript - Seeking Alpha